CONMED Corporation
CNMDNYSEHealthcare● Active
$34.97
$-0.19(-0.54%)
Market Cap$1.1B
P/E Ratio—
52W High$60.35
52W Low$32.13
CONMED Corporation (CNMD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CNMD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
$0.89
Est. $0.82 · +8.5%
Revenue
$0.32B
Est. $0.31B · +2.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 9-Quarter EPS Beat Streak
CNMD reports quarterly as a NYSE-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | $1.10 | — | — | — | $0.34B | — |
| ▲ Q2 FY2026 | Apr 29, 2026 | $0.82 | $0.89 | +8.5% | $0.32B | $0.31B | +2.1% |
| ▲ Q1 FY2026 | Jan 28, 2026 | $1.32 | $1.43 | +8.3% | $0.37B | $0.37B | +1.7% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $1.05 | $1.08 | +2.9% | $0.34B | $0.37B | -7.9% |
| ▲ Q3 FY2025 | Jul 30, 2025 | $1.13 | $1.15 | +1.8% | $0.34B | $0.33B | +2.3% |
| ▲ Q2 FY2025 | Apr 30, 2025 | $0.81 | $0.95 | +17.3% | $0.32B | $0.31B | +2.5% |
| ▲ Q1 FY2025 | Feb 5, 2025 | $1.20 | $1.34 | +11.7% | $0.35B | $0.34B | +2.0% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $0.99 | $1.05 | +6.1% | $0.32B | $0.32B | -0.5% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
$1.10
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026Beat
EPS Actual
$0.89
EPS Est.
$0.82
EPS Surpr.
+8.5%
Revenue
$0.32B
Q1 FY2026
Jan 28, 2026Beat
EPS Actual
$1.43
EPS Est.
$1.32
EPS Surpr.
+8.3%
Revenue
$0.37B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$1.08
EPS Est.
$1.05
EPS Surpr.
+2.9%
Revenue
$0.34B
Q3 FY2025
Jul 30, 2025Beat
EPS Actual
$1.15
EPS Est.
$1.13
EPS Surpr.
+1.8%
Revenue
$0.34B
Q2 FY2025
Apr 30, 2025Beat
EPS Actual
$0.95
EPS Est.
$0.81
EPS Surpr.
+17.3%
Revenue
$0.32B
Q1 FY2025
Feb 5, 2025Beat
EPS Actual
$1.34
EPS Est.
$1.20
EPS Surpr.
+11.7%
Revenue
$0.35B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$1.05
EPS Est.
$0.99
EPS Surpr.
+6.1%
Revenue
$0.32B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.59 | $1.60 | $1.62 | 3 |
| Q3 FY2028 | $1.32 | $1.34 | $1.35 | 2 |
| Q2 FY2028 | $1.34 | $1.36 | $1.37 | 2 |
| Q1 FY2028 | $1.16 | $1.17 | $1.18 | 3 |
| Q4 FY2027 | $1.46 | $1.47 | $1.48 | 2 |
| Q3 FY2027 | $1.17 | $1.18 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.4B | $0.4B | $0.4B | 2 |
| Q3 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q2 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q1 FY2028 | $0.3B | $0.3B | $0.4B | 2 |
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 3 |
| Q3 FY2027 | $0.3B | $0.4B | $0.4B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 29, 2026 | +8.5% | $36.79 | $35.96 | -2.26% |
| ▲ Q1 FY2026 | Jan 28, 2026 | +8.3% | $39.58 | $38.69 | -2.25% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +2.9% | $45.71 | $44.44 | -2.78% |
| ▲ Q3 FY2025 | Jul 30, 2025 | +1.8% | $50.29 | $50.14 | -0.30% |
| ▲ Q2 FY2025 | Apr 30, 2025 | +17.3% | $51.17 | $49.11 | -4.03% |
| ▲ Q1 FY2025 | Feb 5, 2025 | +11.7% | $72.88 | $74.00 | +1.54% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +6.1% | $64.68 | $65.26 | +0.90% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +7.7% | $69.52 | $69.04 | -0.69% |
Q2 FY2026-2.26%
Report Date
Apr 29, 2026
EPS Beat/Miss
+8.5%
Price Before
$36.79
Price After
$35.96
Q1 FY2026-2.25%
Report Date
Jan 28, 2026
EPS Beat/Miss
+8.3%
Price Before
$39.58
Price After
$38.69
Q4 FY2025-2.78%
Report Date
Nov 5, 2025
EPS Beat/Miss
+2.9%
Price Before
$45.71
Price After
$44.44
Q3 FY2025-0.30%
Report Date
Jul 30, 2025
EPS Beat/Miss
+1.8%
Price Before
$50.29
Price After
$50.14
Q2 FY2025-4.03%
Report Date
Apr 30, 2025
EPS Beat/Miss
+17.3%
Price Before
$51.17
Price After
$49.11
Q1 FY2025+1.54%
Report Date
Feb 5, 2025
EPS Beat/Miss
+11.7%
Price Before
$72.88
Price After
$74.00
Q4 FY2024+0.90%
Report Date
Oct 30, 2024
EPS Beat/Miss
+6.1%
Price Before
$64.68
Price After
$65.26
Q3 FY2024-0.69%
Report Date
Jul 31, 2024
EPS Beat/Miss
+7.7%
Price Before
$69.52
Price After
$69.04
Avg Beat Reaction-1.23%
Beat Rate8 / 8 quarters
Largest Move-4.03% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CNMD ends December
CONMED Corporation (CNMD) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $0.89 — beating the analyst consensus of $0.82 by +8.5%. CNMD has beaten EPS estimates for 9 consecutive quarters. The next CNMD earnings date is expected around September 1, 2026.
Each quarter, investors track CNMD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CNMD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CNMD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CNMD earnings · 5 questionsCONMED Corporation's next earnings report is expected around September 1, 2026. CNMD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CNMD historically reports after market close (AMC).
CNMD earnings datewhen is CNMD earningsCNMD next earnings datewhen does CNMD report earningsCNMD earnings calendar
▸ Source: FMP · CONMED Corporation SEC filings · US GAAP · CONMED Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026